Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1977 1
1980 1
1985 1
1987 1
1988 1
1989 1
1990 1
1992 1
1996 1
2001 1
2002 1
2003 3
2004 2
2005 5
2006 5
2007 6
2008 5
2009 6
2010 12
2011 12
2012 5
2013 6
2014 7
2015 11
2016 7
2017 16
2018 10
2019 4
2020 14
2021 22
2022 23
2023 30
2024 32
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination.
Joshi S, Anantharaman D, Muwonge R, Bhatla N, Panicker G, Butt J, Rani Reddy Poli U, Malvi SG, Esmy PO, Lucas E, Verma Y, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sankaran S, Pillai Rameshwari Ammal Kannan T, Kartha P, Shastri SS, Sauvaget C, Radhakrishna Pillai M, Waterboer T, Müller M, Sehr P, Unger ER, Sankaranarayanan R, Basu P. Joshi S, et al. Among authors: verma y. Vaccine. 2023 Jan 4;41(1):236-245. doi: 10.1016/j.vaccine.2022.11.044. Epub 2022 Nov 26. Vaccine. 2023. PMID: 36446654 Free PMC article.
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study.
Basu P, Malvi SG, Joshi S, Bhatla N, Muwonge R, Lucas E, Verma Y, Esmy PO, Poli URR, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sankaran S, Prabhu PR, Kannan TPRA, Varghese R, Shastri SS, Anantharaman D, Gheit T, Tommasino M, Sauvaget C, Pillai MR, Sankaranarayanan R. Basu P, et al. Among authors: verma y. Lancet Oncol. 2021 Nov;22(11):1518-1529. doi: 10.1016/S1470-2045(21)00453-8. Epub 2021 Oct 8. Lancet Oncol. 2021. PMID: 34634254 Free PMC article.
Robust estimation of bacterial cell count from optical density.
Beal J, Farny NG, Haddock-Angelli T, Selvarajah V, Baldwin GS, Buckley-Taylor R, Gershater M, Kiga D, Marken J, Sanchania V, Sison A, Workman CT; iGEM Interlab Study Contributors. Beal J, et al. Commun Biol. 2020 Sep 17;3(1):512. doi: 10.1038/s42003-020-01127-5. Commun Biol. 2020. PMID: 32943734 Free PMC article.
Bevacizumab: The future of chronic subdural hematoma.
Verma Y, Abdelghaffar M, Verma O, Gajjar A, Ghozy S, Kallmes DF. Verma Y, et al. Interv Neuroradiol. 2024 Nov 21:15910199241298727. doi: 10.1177/15910199241298727. Online ahead of print. Interv Neuroradiol. 2024. PMID: 39569567 Free PMC article. Review.
Non-endoscopic biopsy techniques: a review.
Otuya DO, Verma Y, Farrokhi H, Higgins L, Rosenberg M, Damman C, Tearney GJ. Otuya DO, et al. Among authors: verma y. Expert Rev Gastroenterol Hepatol. 2018 Feb;12(2):109-117. doi: 10.1080/17474124.2018.1412828. Epub 2017 Dec 15. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29241376 Free article. Review.
Tumor reversion: a dream or a reality.
Tripathi A, Kashyap A, Tripathi G, Yadav J, Bibban R, Aggarwal N, Thakur K, Chhokar A, Jadli M, Sah AK, Verma Y, Zayed H, Husain A, Bharti AC, Kashyap MK. Tripathi A, et al. Among authors: verma y. Biomark Res. 2021 May 6;9(1):31. doi: 10.1186/s40364-021-00280-1. Biomark Res. 2021. PMID: 33958005 Free PMC article. Review.
A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination.
Malvi SG, Esmy PO, Muwonge R, Joshi S, Poli URR, Lucas E, Verma Y, Lucksom PG, Shah A, Patel B, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sauvaget C, Sankaran S, Kannan TPRA, Shastri SS, Pillai MR, Anantharaman D, Bhatla N, Sankaranarayanan R, Basu P. Malvi SG, et al. Among authors: verma y. J Natl Cancer Inst Monogr. 2024 Nov 1;2024(67):317-328. doi: 10.1093/jncimonographs/lgae042. J Natl Cancer Inst Monogr. 2024. PMID: 39529521 Free PMC article. Clinical Trial.
229 results